{"product_id":"ucsf-41st-annual-advances-in-heart-disease-2024","title":"UCSF 41st Annual Advances in Heart Disease 2024","description":"\u003ch3 class=\"product_title entry-title\"\u003eUCSF 41st Annual Advances in Heart Disease 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 5 videos, size: 7.91 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care physician assistants\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eOur 41st annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of weight loss drugs and heart health, heart failure, contemporary management of arrhythmias, critical care cardiology, mechanical circulatory support, erectile dysfunction and heart health, and pulmonary hypertension.\u003cbr\u003e\u003cbr\u003eOur faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.\u003cbr\u003e\u003cbr\u003eAll sessions will be recorded and made available to participants for online viewing 30 days post course.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTARGET AUDIENCE\u003c\/strong\u003e\u003cbr\u003eThis course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003eObjectives\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eProviding the Best Management of Coronary Heart Disease, Hypertension, Lipid Disorders, Diabetes, Systolic and Diastolic Heart Failure, Atrial Fibrillation and Flutter, STEMI and Non-STEMI, Thromboembolic Disease;\u003c\/li\u003e\n\u003cli\u003eRefining Considerations for Atrial Fibrillation, Atrial Flutter, and Ventricular Tachycardia Ablation;\u003c\/li\u003e\n\u003cli\u003eApplying the Best Considerations of Percutaneous Interventions for Coronary Heart Disease;\u003c\/li\u003e\n\u003cli\u003eImproving the Use of Anti-Platelet and Anti-Coagulation Therapy for Cardiovascular Diseases;\u003c\/li\u003e\n\u003cli\u003eRecognizing Risk Stratification of Cardiovascular Disease;\u003c\/li\u003e\n\u003cli\u003eOptimizing the Management of Peripheral Artery Disease;\u003c\/li\u003e\n\u003cli\u003eRecognizing that Pathophysiology of Diseases and Treatment Options Differ among Racial and Ethnic Groups;\u003c\/li\u003e\n\u003cli\u003eOptimizing the Management of COVID-19 and its Cardiovascular Complications.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDecember 6 AM Session.mp4\u003c\/li\u003e\n\u003cli\u003eDecember 6 PM Session.mp4\u003c\/li\u003e\n\u003cli\u003eDecember 7 AM Session.mp4\u003c\/li\u003e\n\u003cli\u003eDecember 7 PM Session.mp4\u003c\/li\u003e\n\u003cli\u003eDecember 8 AM Session.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e* Detail:\u003cbr\u003e\u003ctable cellpadding=\"0\" cellspacing=\"0\" width=\"1864\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"3\"\u003e\u003cstrong\u003eFriday, December 6, 2024\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"80\"\u003e7:00 AM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eRegistration and Continental Breakfast\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd width=\"296\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:00\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eWelcome and Symposium Overview\u003c\/td\u003e\n\u003ctd\u003ePeter Ganz, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eSession: Frontiers in Interventional Cardiology\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eChair: Lucas Zier, MD, MS \u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eMyocardial Infarction Without Obstructive Coronary Disease. What to Do?\u003c\/td\u003e\n\u003ctd\u003eKrishan Soni, MD, MBA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:45\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eComplete Revascularization vs Culprit Only Revascularization: Understanding Each Strategy and When to Perform Each Approach\u003c\/td\u003e\n\u003ctd\u003eAda Ip, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:25\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eOrbita vs Orbita 2: Update on PCI for Stable CAD.\u003c\/td\u003e\n\u003ctd\u003eLucas Zier, MD, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eCoffee Break\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:20\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e2024 Updates on the Management of Valve Disease\u003c\/td\u003e\n\u003ctd\u003eSammy Elmariah , MD, MPH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:00\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eSurgical Management of Type A Aortic Dissection\u003c\/td\u003e\n\u003ctd\u003eRamin Beygui, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:40\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eCirculatory Support in Cardiogenic Shock: New Data and a New Era?\u003c\/td\u003e\n\u003ctd\u003eConnor O’Brien, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:20 PM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eLunch (on Your Own)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eSession: Managing Heart Failure\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eChair: Jonathan Davis, MD, MPH\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:40 PM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eNew Drugs and Devices Coming Down Pipeline for Heart Failure\u003c\/td\u003e\n\u003ctd\u003eLiviu Klein, MD, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:15\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eGenetic Testing for Heart Failure, Who Should Be Tested and What are We Looking For?\u003c\/td\u003e\n\u003ctd\u003eJulianne Wojciak, LGCG, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:50\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eHFrEF Management\u003c\/td\u003e\n\u003ctd\u003eJonathan Davis, MD, MPH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:25\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eCoffee Break\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:40\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eHFpEF Management\u003c\/td\u003e\n\u003ctd\u003eJacqueline DesJardin, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:15\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eApproach to and Management of Hypertrophic Cardiomyopathy\u003c\/td\u003e\n\u003ctd\u003eTheodore Abraham, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:50\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eApproach to and Management of Cardiac Amyloid\u003c\/td\u003e\n\u003ctd\u003eMandar Aras, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:25 PM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eAdjourn\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"3\"\u003e\u003cstrong\u003eSaturday, December 7, 2024\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30 AM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eContinental Breakfast\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:00\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eAnnouncements\u003c\/td\u003e\n\u003ctd\u003ePeter Ganz, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eSession: Advances and Controversies in Electrophysiology\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eChair: Nora Goldschlager, MD\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eUse and Misuse of Antiarrhythmic Drugs in 2025\u003c\/td\u003e\n\u003ctd\u003eGregory Marcus, MD, MAS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:45\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eExtravascular Pacemakers and ICDs: Where Have All the Leads Gone?\u003c\/td\u003e\n\u003ctd\u003eAdam Oesterle, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:25\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eConduction System Pacing: Benefits, Outcomes and Risks\u003c\/td\u003e\n\u003ctd\u003eJoshua Moss, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eCoffee Break\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:20\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eArrhythmogenic  Cardiomyopathy\u003c\/td\u003e\n\u003ctd\u003eMelvin Scheinman, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:00\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eWhat to Do with Incidentally Detected Atrial Fibrillation\u003c\/td\u003e\n\u003ctd\u003eCara Pellegrini, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:40\u003c\/td\u003e\n\u003ctd width=\"566\"\u003ePVCs and non-Sustained VT. When to Worry.\u003c\/td\u003e\n\u003ctd\u003eEdward Gerstenfeld, MD, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:20\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eLunch (on your own)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:40 PM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eAchieving a Successful Ablation. Achieving a Successful Ablation. Patient Selection and Outcomes.\u003c\/td\u003e\n\u003ctd\u003eThomas Dewland, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eSession: Cardiovascular Risk Reduction and Prevention\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eChair: Peter Ganz, MD\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:20\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eElliot Rapaport Keynote Lecture: How Failed Diabetes Drugs Led to a Revolution in Diabetes and Heart Failure Care. Convincing the FDA to Mandate Cardiovascular Outcome Trials for Diabetes Drug Approval\u003c\/td\u003e\n\u003ctd\u003eSteven Nissen, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eNew Prediction Tools from the AHA for Risk Assessment of Cardiovascular Disease\u003c\/td\u003e\n\u003ctd\u003ePeter Ganz, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:45\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eCoffee Break\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:00\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eCardiovascular Disease in Type 1 Diabetes\u003c\/td\u003e\n\u003ctd\u003eRobert Eckel, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:40\u003c\/td\u003e\n\u003ctd width=\"566\"\u003ePulmonary Hypertension, Contemporary Management and When to Refer\u003c\/td\u003e\n\u003ctd\u003eMarc Simon, MD, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:20 PM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eAdjourn\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"3\"\u003e\u003cstrong\u003eSunday, December 8, 2024\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30 AM\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eContinental Breakfast\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:00\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eAnnouncements\u003c\/td\u003e\n\u003ctd\u003ePeter Ganz, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eSession: Understanding and Managing Cardiovascular Risk\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eChair: Peter Ganz, MD\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eSex diversity in heart-liver-metabolic axis risks and outcomes\u003c\/td\u003e\n\u003ctd\u003eSusan Cheng, MD, MMSc, MPH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:45\u003c\/td\u003e\n\u003ctd width=\"566\"\u003ePDE-5 inhibitors for Erectile Dysfunction: Do They Have Cardiovascular Protective Properties\u003c\/td\u003e\n\u003ctd\u003eRobert Kloner, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:25\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eThe Interplay of Cardiovascular and Kidney Disease\u003c\/td\u003e\n\u003ctd\u003eJulio Lamprea Montealegre, MD, PhD, MPH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eInsights from Basic Science to Advance Understanding of Heart Failure\u003c\/td\u003e\n\u003ctd\u003eArun Padmanabhan, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:25\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eWeight Loss Drugs and Heart Health\u003c\/td\u003e\n\u003ctd\u003eMartha Gulati, MD, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:05\u003c\/td\u003e\n\u003ctd width=\"566\"\u003eManagement of Stroke – Updates\u003c\/td\u003e\n\u003ctd\u003eLauren Patrick, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:45\u003c\/td\u003e\n\u003ctd width=\"566\"\u003e\u003cem\u003eAdjourn\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954491068514,"sku":"MED-AMB04449","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UCSF-41st-Annual-Advances-in-Heart-Disease-2024.jpg?v=1779377874","url":"https:\/\/meducourse.com\/products\/ucsf-41st-annual-advances-in-heart-disease-2024","provider":"Meducourse","version":"1.0","type":"link"}